Matrix metallopropteinases in heart failure.
Heart failure (HF) represents a complex multifactorial syndrome, characterized by crucial structural and functional abnormalities of the myocardium. Matrix metalloproteinases are associated with left ventricular dysfunction, adverse left ventricular remodelling and prognosis after acute myocardial i...
Үндсэн зохиолчид: | Tousoulis, D, Kampoli, A, Papageorgiou, N, Antoniades, C, Siasos, G, Latsios, G, Tsiamis, E, Stefanadis, C |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2012
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
-н: Kampoli, A, зэрэг
Хэвлэсэн: (2012) -
Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
-н: Briasoulis, A, зэрэг
Хэвлэсэн: (2012) -
Circulating biomarkers for the diagnosis and prognosis of heart failure.
-н: Tousoulis, D, зэрэг
Хэвлэсэн: (2009) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
-н: Gounari, P, зэрэг
Хэвлэсэн: (2010) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
-н: Tousoulis, D, зэрэг
Хэвлэсэн: (2011)